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ㅋ
Cyclic vomiting syndrome (CVS) is a functional gastrointestinal disorder that can occur in both children and adults. Clinical 
courses of CVS manifesting recurrent severe vomiting episodes and interval illness may affect the long-term quality of life in 
children with CVS. Therefore, we should be careful in accessing a patient suggestive of CVS. Accurate diagnosis based on di-
agnostic criteria for CVS and the exclusion from other organic diseases mimicking clinical manifestations of cyclic vomiting is 
absolutely required. In patients diagnosed as CVS, optimal therapy should be performed to improve symptoms and to reduce 
complications in prodromal phase and emetic phase, and long-term prophylactic therapy should be tried to prevent the devel-
opment of vomiting episodes. The identification of triggering factors which induce vomiting episodes might be helpful in pre-
venting vomiting attacks. Systematic approach should be recommended to improve clinical outcome of CVS.
(J Neurogastroenterol Motil 2010;16:139-147)
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Introduction
Cyclic vomiting syndrome (CVS) is a disorder characterized 
by recurrent episodes of nausea and severe vomiting with symp-
tom-free intervals between the episodes and stereotypic patterns 
within individuals.
1 CVS is classified as one of the functional gas-
trointestinal disorders based on the Rome III.
2,3 Thorough inves-
tigations to distinguish CVS from various organic disorders man-
ifesting with cyclic vomiting, are required.
In this review article, the diagnostic criteria and clinical fea-
tures of CVS will be investigated, and also recent concepts on the 
diagnosis, treatment, prophylaxis, and clinical outcomes of CVS 
will be discussed.
Diagnostic Criteria of
  Cyclic Vomiting Syndrome
CVS was first described by Gee
4 in the St. Bartholomew’s 
Hospital Reports of 1882. CVS is a functional disorder featured 
by recurrent discrete episodes of intense nausea and vomiting - 
median 6 times per hour at peak -, lasting hours to days and inter-
val wellness returning to usual status.
4
　The first diagnostic criteria of CVS were set up at the 1st in-Hye Ran Yang
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Table 1. Rome III Criteria for Cyclic Vomiting Syndrome in Children and Adults
2,3,7
Children Adults 
Must include all of the following:
  1. Two or more periods of intense nausea and unremitting 
vomiting or retching lasting hours to days
  2. Return to usual state of health lasting weeks to months
Must include all of the following:
  1. Stereotypical episodes of vomiting regarding onset (acute) and
duration (less than 1 wk)
  2. Three or more discrete episodes in the prior year
  3. Absence of nausea and vomiting between episodes
Supportive criterion
  History or family history of migraine headaches.
  *Criteria fulfilled for the last 3 mo with symptom onset at least 6 mo
before diagnosis
Table 2. New Diagnostic Criteria for Children With Cyclic 
Vomiting Syndrome Suggested by the North American Society for 
Pediatric Gastroenterology, Hepatology, and Nutrition Consensus
Statement
8
All of the criteria must be met to meet this consensus definition of 
cyclic vomiting syndrome.
1. At least 5 attacks in any interval, or a minimum of 3 attacks during 
a 6 mo period
2. Episodic attacks of intense nausea and vomiting lasting 1 hr-10 
days and occurring at least 1 wk apart
3. Stereotypical pattern and symptoms in the individual patient
4. Vomiting during attacks occurs at least 4 times/hr for at least 1 hr 
5. Return to baseline health between episodes
6. Not attributed to another disorder
ternational symposium on CVS held in 1994.
5 Thereafter, a re-
vised criteria for CVS at the 2nd international scientific sympo-
sium held in 1998, the Rome II criteria in 1999, and the Rome 
III criteria in 2006 were suggested as new clinical criteria for 
CVS.
2,3,6 The most noticeable point is that previous criteria of 
CVS were only for children, but a newly developed Rome III cri-
teria for functional gastrointestinal disorders is including the di-
agnostic criteria of CVS for both children and adults (Table 
1).
2,3,7
In 2008, new diagnostic criteria for CVS in childhood were 
suggested as a part of the North American Society for Pediatric 
Gastroenterology, Hepatology, and Nutrition consensus state-
ment on the diagnosis and management of CVS (Table 2).
8
Epidemiology of
  Cyclic Vomiting Syndrome
CVS had been regarded as a rare disease before, but now it 
seems to be relatively common in pediatric population with the 
prevalence between 1.9% and 2.3% according to the data of pre-
vious reports.
9,10 The annual incidence of CVS was 3.15 per 
100,000 children for 2005 in Ireland.
11 
There are no data on the prevalence of CVS in adults until 
now, but recently there are several articles reporting CVS cases in 
adults.
12-14 It is assumed that CVS might be more common even 
in adults than expected before.
12
CVS has been reported to be slightly more common in female 
than in male (55:45 or 60:40) in all age groups.
8,12,15,16 
CVS can develop in any age, but it has been mainly reported 
in childhood, with mean age between 4.6 years and 6.9 years.
9,16,17 
There are some reports on adults with CVS, and in adults, mean 
age at initial diagnosis was 34.8 years.
17,18 In many patients with 
CVS, it took several months to years in making a definite diag-
nosis for CVS.
Clinical Features of
  Cyclic Vomiting Syndrome
CVS is clinically characterized by recurrent, stereotypic epi-
sodes of intense nausea and vomiting lasting hours to days that 
are separated by symptom-free intervals lasting weeks to months.
4 
‘Stereotypic’ episode means that each episode is similar within in-
dividuals as to time of onset, intensity, duration, frequency, and 
associated symptoms and signs. CVS typically has 3 phases: pro-
dromal phase, emetic phase, and well phase between the episodes. 
Approaching the patient according to each phase is clinically im-
portant to diagnose and treat a patient with CVS.
Approximately 40-80% of CVS patients are having their own 
triggering factors evoking vomiting episodes.
15,16,19 Psychologi-
cally excessive stress and emotionally excited state are the most 
common triggers. Infections (sinusitis, respiratory infection), Cyclic Vomiting Syndrome in Children
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Table 3.  Comparison of Clinical Features Between Children and 
Adults With Cyclic Vomiting Syndrome (Adapted and Modified 
From Abell et al.
17)
Children Adults
Age at diagnosis 4.6-5.3 yr 34.8 yr
Delay in diagnosis 2.6-3.1 yr   7.9 yr
Duration of episodes       2.0 days  3.8 days
Interepisode intervals 1.0-3.1 mo 3.0 mo
Prodromal symptoms Common Common
Symptoms during episode
Vomiting Universal Universal
Abdominal pain Common Common
Interepisodic nausea  Rare Common
  or dyspepsia
Associated psychiatric  Common Common
  manifestations
Migraine headache Common Common
  or family history of
  migraine headache
motion sickness, physical exhaustion, excessive exercise, over-
eating, specific foods (chocolate, cheese, etc.), menstruation, hot 
weather, and asthmatic attacks also can trigger vomiting episode 
in CVS patients.
16,19
About one third of CVS patients show prodromal symptoms 
before vomiting episodes attack. Prodromal symptoms of CVS 
consist of change in mood, aura common in migraine, abdominal 
pain, dyspepsia, nausea, easy fatigability, anxiety, headache, diz-
ziness, etc.
9,15,20 
Vomiting episodes of CVS usually begin at the same time of 
day stereotypically, especially at dawn and in the morning.
9,15,16 
Vomiting episodes repeat 4-12 times a year showing similar pat-
terns in each patient.
9,19,21 Episodes usually continue from 2 
hours to 10 days, and CVS patients show intensive emesis that de-
velop minimum 4 vomiting per hour during the first hours of 
each episode. 
Every vomiting episode eventually resolves spontaneously 
even if left untreated. Most patients return to usual health con-
dition as soon as the episode stops. However, more than one third 
of CVS patients can show vomiting symptoms even during well 
phase between the vomiting episodes.
Intense vomiting during the episodes is associated with other 
symptoms in most patients with CVS. Nausea and abdominal 
pain on periumbilical or epigastric area are the most common as-
sociated symptoms. Headache, mild fever, loose stools, excessive 
drooling, photophobia, intolerance to noise, pallor, tachycardia, 
and mild elevation of blood pressure are also common.
16,18,21 
Leukocytosis is often observed during vomiting episodes in CVS 
patients.
Various complications may occur related to vomiting 
symptoms. Massive prolonged vomiting can cause dehydration 
and electrolyte imbalance in emetic phase. Gastritis, esophagitis, 
Mallory-Weiss tear, weight loss, dental caries, and psychiatric 
problems including social withdrawal and depression, can be 
complicated secondary to intensive vomiting episodes.
20,22
Clinical manifestations of CVS in children are somewhat dif-
ferent from those of adult patients (Table 3).
17 Duration of each 
vomiting episodes are shorter in children than in adults.
12,17 
Interepisodic nausea or dyspepsia is rare in children with CVS, 
but common in adult patients.
17 Some adult patients are initially 
misdiagnosed as gastroparesis due to clinical similarity. Namin et 
al.
14 reported that 5% of adult patients suspected to be gastro-
paresis finally turn out to be CVS. Therefore, the diagnosis for 
CVS is more frequently delayed in adults than in children.
However, in a study by Prakash et al. in 2001,
13 it was re-
garded that there were striking similarities in clinical manifes-
tations across age groups. The only difference was the duration of 




  Cyclic Vomiting Syndrome
Migraine and motion sickness are commonly associated with 
vomiting episodes of CVS. According to previous studies, 
11-21% of CVS patients accompany migraine headache, and 
29-46% accompany motion sickness.
9,20 Migraine and family his-
tory of migraine were noted in 39-81% of CVS patients in child-
hood, and in 24-70% of adult patients.
17
Even more, both irritable bowel syndrome and family history 
of irritable bowel syndrome are more common in CVS patients 
(67% vs. 62%) than in general population (10-20% vs. 14%).
23 
Epilepsy is approximately 10 times more common in CVS 
patient than in general population.
16,23 However, there was no 
CVS patient showing epileptic seizure in Korea.
15 
Children with CVS often accompany psychiatric disorders 
such as anxiety disorders or depression.
24
Family history of CVS was also common in CVS patients 
(3%) than in general population (0.4-2.0%).
23Hye Ran Yang
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Table 4. Differential Diagnosis of Cyclic Vomiting in Children and Adolescents (Adapted and Modified From Forbes et al.
26)
Gastrointestinal disorders
Bowel obstruction (malrotation with volvulus, internal hernia, duplication cyst, and intermittent duodenal intussuception)
Inflammatory diseases (gastritis, duodenitis, peptic ulcer disease, chronic appendicitis, and inflammatory bowel disease)
Pancreatid diseases (pancreatitis and pancreatic pseudocyst)
Hepatobiliary disease (hepatitis)
Infections
Enteric agents (Giardiasis, Gastrospirillium, Entamoeba coli, Blastocystis hominis, and pinworms)




Space occupying central nervous system lesions (hydrocephalus, posterior fossa tumors, subdural hematoma, and subdural effusion)
Familial dysautonomia
Metabolic and endocrine disorders
Diabetes mellitus, Addison disease, and pheochromocytoma
Aminoaciduria, organic aciduria, fatty acid oxidation disorders, mitochondrial disorders, and urea cycle defects
Medications and toxins









Benign paroxysmal positional vertigo
Differential Diagnosis of
  Cyclic Vomiting Syndrome
Cyclic vomiting occurs not only in CVS patients but also in 
other organic diseases clinically mimicking CVS. Therefore, the 
diagnosis of CVS should be done very carefully, ruling out all 
possible organic causes of cyclic vomiting. Previous study re-
ported that among patients manifested as cyclic vomiting, 5% had 
gastrointestinal disorders, 7% were due to other organic dis-
orders, and only 88% were compatible with CVS.
25 
Clinically differential diagnosis of CVS includes gastro-
intestinal disorders such as bowel obstruction, inflammatory dis-
ease of gastrointestinal tracts, pancreatic diseases, and hep-
atobiliary diseases; infectious diseases such as parasite infestation 
and protozoa infection, otitis media, chronic sinusitis, and hep-
atitis; neurologic disorders such as migraine, epilepsy, and space 
occupying CNS lesions; metabolic and endocrine disorders such 
as diabetes mellitus, Addison disease, pheochromocytoma, ami-
noaciduria, organic aciduria, fatty acid oxidation disorders, mi-
tochondrial disorders, and urea cycle defects; medications and 
toxins such as antibiotics, NSAIDs, laxatives, high dose fat solu-
ble vitamins, hormones, etc.; urologic/gynecologic disorders such 
as pelvi-ureteric junction obstruction and nephrolithiasis; and 
miscellaneous disorders and psychiatric disorders (Table 4).
26
Suggested Hypotheses on the Pathogenesis
  of Cyclic Vomiting Syndrome
The etiology and pathogenesis of CVS still remain unknown. 
It is assumed that various factors can affect the development of 
vomiting episodes in CVS, and severe hypotheses have been sug-
gested as possible etiologies: migraine variant,
27 mitochondrial dis-
eases including mitochondrial fatty acid oxidation disorders,
28,29 
gastrointestinal motility disorder,
30 corticotropin-releasing factor in 
response to stress,
31 disorder of the brain-gut axis,
32 autonomic 
dysfunction,
33 abdominal epilepsy, ion channel dysfunction, and 
altered psychodynamics, etc.
Recent concept on CVS is mitochondrial energy depletion 
due to mitochondrial mutation along with precipitating stress or Cyclic Vomiting Syndrome in Children
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Figure 1. Recommended diagnostic al-
gorithm of cyclic vomiting syndrome in 
children.
excitement may predispose the onset of vomiting episodes in pa-
tients with CVS.
34 
Genetic association including A3243G mitochondrial DNA 
mutation was also suggested as the possible cause of CVS.
35 
Food allergy was also suggested as a possible pathogenesis of 
CVS by Lucarelli et al.
36 in 2000. However, there have been no 
more studies on the relationship between CVS and food allergy; it 
is yet controversial.
Diagnostic Evaluation for
  Children with Cyclic Vomiting
Thorough history taking and physical examination are essen-
tial to diagnose the CVS and to rule out organic diseases causing 
cyclic vomiting. Alarm symptoms and signs are important clues 
for the differential diagnosis of cyclic vomiting in children. 
Suspicious alarm symptoms and signs clinically suggestive of or-
ganic diseases are bilious vomiting, severe abdominal pain ac-
companied by abdominal tenderness, hematemesis, attacks pre-
cipitated by acute illness and prior fasting or high protein meal, 
neurologic symptoms and signs (such as irritability, altered men-
tal status, seizure, abnormal eye movements, papilledema, and 
motor asymmetry), and progressively worsening vomiting 
episodes.
8 These symptoms and signs are mainly indicating the 
possibility of significant gastrointestinal diseases, metabolic dis-
orders, neurologic diseases, or other organic diseases manifesting 
cyclic vomiting.
8
Laboratory studies including complete blood count, liver 
function tests, electrolytes, glucose, blood urea nitrogen, crea-
tinine, amylase, lipase, ammonia, urinalysis, and pregnancy test 
for adolescents, are basically recommended in all patients. 
Laboratory metabolic findings include hypoglycemia, sub-
stantial anion gap metabolic acidosis, respiratory alkalosis, or hy-
perammonemia especially during vomiting episodes.
8 Therefore, 
if clinically indicated, additional laboratory tests such as lactate, 
pyruvate, organic acid and amino acid analysis, plasma carnitine 
and acylcarnitine, plasma cortisol levels, and urinary prophyrins 
can be performed to exclude the possibility of metabolic and en-
docrine disorders.
8 
Barium contrast study of upper gastrointestinal tract with 
small bowel follow through, abdominal sonography, or abdomi-
nal computed tomography are useful radiologic methods to find 
out organic lesions possibly which can cause cyclic vomiting 
features. Barium studies are usually performed to rule out organ-Hye Ran Yang
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Table 5. Recommended Prophylactic Drugs for Children With 
Cyclic Vomiting Syndrome (Adapted and Modified From 
NASPGHAN consensus
8)
In children 5 yr or younger
Antihistamines: 
Cyproheptadine (0.25 to 0.5 mg/kg/day divided bid or tid )
  - first choice
Alternatives: pizotifen
β-Blockers: 
Propranolol (0.25 to 1.0 mg/kg/day divided bid or tid) with
  heart rate monitoring - second choice
In children older than 5 yr
Tricyclic antidepressants: 
Amitriptyline (begin at 0.25 to 0.5 mg/kg, increase up to
  1.0-1.5 mg/kg) with electrocardiogram monitoring for
  QTc interval before starting and 10 days after peak dose
  - first choice
Alternatives: nortriptyline
β-Blockers: 
Propranolol (0.25 to 1.0 mg/kg/day divided bid or tid) with
  heart rate monitoring - second choice
Other agents
Anticonvulsants: Phenobarbital 
Alternatives: topiramate, valproic acid, gabapentin
Coenzyme Q10 (10 mg/kg/day divided bid or tid, max 100 mg tid)
L-carnitine (50 to 100 mg/kg/day divided bid or tid, max 1 g tid)
NASPGHAN, North American Society for Pediatric Gastroenterology, 
Hepatology, and Nutrition; QTc, corrected QT. 
ic gastrointestinal diseases including chronic intestinal pseu-
do-obstruction and malrotation.
17 Esophagogastroduodenoscopy 
is recommended to rule out upper gastrointestinal disorders like 
peptic ulcer diseases.
If a patient reveals neurologic manifestations, electro-
encephalography and brain magnetic resonance imaging can be 
excellent diagnostic tools to detect intracranial abnormalities.
8
Recommended diagnostic algorithm of the CVS in children 
is shown in Figure 1.
Strategies for the Treatment of
  Cyclic Vomiting Syndrome
1. Prophylactic therapy in prodromal phase
When children diagnosed as CVS begin to manifest pro-
dromal symptoms, various therapeutic trials can be applied to 
prevent the attack of vomiting episode. These kinds of prophy-
lactic therapy in prodromal phase includes the control of stressful 
life style (lying down in a dark, quiet environment or hot bath), 
high carbohydrate ingestion, anti-emetic agents (ondansetron 
and granisetron), anti-anxiety agents (lorazepam), anti-migraine 
agents (sumatriptan and zolmitriptan),
17 and has been mainly 
tried in pediatric patients. However, the effectiveness of these 
therapies was not proved due to the lack of data.
Recommended medications during prodromal phase of CVS 
are as follows: 5-HT3 receptor antagonists (ondansetron and gra-
nisetron), anti-histamines (diphenhydramine), phenothiazines 
(promethazine), benzodiazepines (lorazepam), and anti-migraine 
agent (sumatriptan).
8,17
Recently, the Pediatric Guidelines Committee of North 
American Society for Pediatric Gastroenterology, Hepatology 
and Nutrition commented on the efficacy of anti-migraine 
5HT1B/1D receptor agonists (sumatriptan) during prodromal 
phase or early phase of emetic episodes in children with family 
history of migraine.
8 Actually, this 5HT1B/1D receptor agonist 
was not approved for use in children and adolescents younger 
than 18 years of age. However, it is recommended to try out this 
agent as early as possible to terminate an episode in children 12 
years and older who have mild episodes less than 1 episode per 
month.
8,37
2. Medical treatment for cyclic vomiting syndrome in 
emetic phase
No treatment has been proved to be effective in controlling 
emetic phase of CVS until now. The goal of therapy during em-
etic phase is the termination of vomiting episodes as soon as pos-
sible for a patient to return to usual life and the prevention of 
complications such as dehydration and electrolyte imbalance, 
caused by intensive vomiting.
In acute phase of emetic episodes, patients should be admit-
ted to the hospital to provide dark, quiet surroundings and to pre-
vent severe dehydration and correct electrolyte imbalance with 
hydration of intravenous fluids. Gastric acid suppressing agents 
including proton pump inhibitors (omeprazole) and H2 receptor 
antagonists (ranitidine) may be helpful in preventing mucosal 
damage of the esophagus.
Intravenous anxiolytic agent, lorazepam (0.05 to 0.1 
mg/kg/dose every 6 hr) is effective in suppressing vomiting 
symptoms or sedate patients in acute emetic episodes. Intrave-
nous injection of 5-HT3 receptor antagonists ondansetron (0.3 to 
0.4 mg/kg/dose every 4 to 6 hr, upper limit of 20 mg/dose) and 
granisetron, or anti-histamine diphenhydramine (1.0 to 1.25 mg/ 
kg/dose every 6 hr) can be tried to reduce vomiting symptoms.
8,17 Cyclic Vomiting Syndrome in Children
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3. Prophylactic therapy during well phase
The goal of long-term prophylactic therapy of CVS is to pre-
vent repetitive vomiting episodes or to decrease the severity of 
symptoms during episodes, thus, allowing patients to continue 
normal life.
Prophylaxis of symptomatic vomiting episodes is focused on 
the identification and avoidance of triggering factors and prophy-
lactic drugs. If precipitants causing vomiting episodes can be 
identified in each patient, it may be possible to prevent the attacks 
of episodes by avoiding stressful events, infection, specific foods, 
sleep deprivation, triggering foods (chocolate and cheese), and 
motion sickness.
26 Life style modification also include avoidance 
of energy-depleted states (fasting, acute infection, and acute ill-
ness) based on Boles’ hypothesis.
35
Medical prophylaxis in children with CVS is composed of 
various medicines that are known to be somewhat effective in pre-
venting vomiting episodes: amitriptyline, cyproheptadine, pro-
pranolol, etc. (Table 5).
8,17  
Based on the similarity in clinical features between CVS and 
migraine, anti-migraine agents (cyproheptidine, pizotifen, pro-
pranolol, etc.) can be tried especially in patients with migraine 
headache or family history of migraine.
38 Cyproheptadine, an-
ti-histamine and serotonin receptor antagonist is effective in 
young children and is the first choice in children 5 years old or 
less.
8,39 And, β-blocker propranolol is recommended as the sec-
ond choice prophylactic drug in children with CVS of all ages.
8
Tricyclic anti-depressive agent, amitriptyline is more effec-
tive as prophylactic drugs in children older than 5 years and 
adults.
39,40 
Although most prophylactic medications are relatively safe 
even in children, heart rate monitoring and electrocardiogram 
monitoring are required while administering and dosing up pro-
pronolol and amitriptyline because these drugs can cause brady-
cardia and arrhythmia, respectively, as side effects.
8
There were several trials on other prophylactic agents. In a 
study by Vanderhoof et al.,
41 oral erythromycin (20 mg/kg/day) 
was tried to patients with CVS as a prokinetic agent, which was 
suggested to be effective in some patients, but the efficacy was not 
confirmed due to poor quality of the study. 
Anti-epileptic drugs were not effective regardless of electro-
encephalogram finding, however, a few studies are reporting the 
efficacy of valproic acid
42 and phenobarbital.
43 
Recently, alternative prophylactic medications including 
coenzyme Q10 and carnitine are suggested to be possibly 
effective.
44,45 
It is difficult to predict the response to medication in 
individuals. Therefore, various factors that can affect the efficacy 
of therapy, that is, age, co-morbid diseases, drug dosage, and ad-
verse effects of drugs, should be considered before initiating pro-
phylactic medication.
8 When the diagnosis for CVS is confirmed 
based on the diagnostic criteria and diagnostic testing, in-
dividualized therapy can be tried with a first-line drug, starting 
from low dose and carefully increasing every 1 to 4 weeks up to 
therapeutic range, for at least 2 cycles of vomiting episodes.
8 If 
the medication is not effective in preventing the attack of episodes 
or if there are significant adverse effects, the second-line drug or 
combination therapy should be considered. However, long-term 
prophylactic strategies are not confirmed yet.
Further studies are needed in the future on the effective pro-
phylaxis of CVS based on its pathogenesis.
Long-term Outcome of Cyclic Vomiting
  Syndrome in Children
It is not easy to predict clinical course and long-term outcome 
of CVS in children due to lack of data. Many patients eventually 
recover from CVS, but some patients suffer from migraine head-
ache later. And, vomiting episodes are repeated even in adulthood 
in more than one third of CVS children.
15,46,47 Therefore, regular 
follow-up and monitoring of disease courses are required in chil-
dren with CVS for a long time or maybe lifelong in some patients.
Conclusion
Because CVS is a relatively common functional gastro-
intestinal disorder in children, we should be careful in approach-
ing the patients manifesting cyclic vomiting. CVS has its own 
unique clinical features of recurrent severe vomiting episodes and 
intervening wellness, which can affect long-term morbidity in 
patients. Early diagnosis applying the diagnostic criteria for CVS 
to rule out organic diseases is important in patients. Recommend-
ed therapeutic strategies for CVS are targeting the reduction of 
symptoms and complications in prodromal phase and emetic 
phase. Long-term prophylaxis is focused on the prevention of 
vomiting episodes. Individualized systematic approach is recom-
mended in children with CVS for accurate diagnosis and better 
clinical outcome.Hye Ran Yang
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